Q
Qianqian Ni
Researcher at Nanjing University
Publications - 37
Citations - 4079
Qianqian Ni is an academic researcher from Nanjing University. The author has contributed to research in topics: Photothermal therapy & Fractional flow reserve. The author has an hindex of 22, co-authored 36 publications receiving 2706 citations. Previous affiliations of Qianqian Ni include National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Coronavirus Disease 2019 (COVID-19): A Perspective from China
TL;DR: This review focuses on the etiology, epidemiology, and clinical symptoms of COVID-19, while highlighting the role of chest CT in prevention and disease control.
Journal ArticleDOI
Toxic Reactive Oxygen Species Enhanced Synergistic Combination Therapy by Self-Assembled Metal-Phenolic Network Nanoparticles.
Yunlu Dai,Yunlu Dai,Zhen Yang,Siyuan Cheng,Zhongliang Wang,Ruili Zhang,Guizhi Zhu,Zhantong Wang,Bryant C. Yung,Rui Tian,Orit Jacobson,Can Xu,Qianqian Ni,Jibin Song,Xiaolian Sun,Gang Niu,Xiaoyuan Chen +16 more
TL;DR: A novel ROS promoted synergistic nanomedicine platform for cancer therapy is established via a biocompatible metal‐polyphenol networks self‐assembly process by encapsulating doxorubicin and platinum prodrugs in nanoparticles.
Journal ArticleDOI
Efficient Nanovaccine Delivery in Cancer Immunotherapy
TL;DR: Aside from peptide antigens, antigen-encoding mRNA for cancer immunotherapy delivered by nanovaccine will also be discussed, and the intracellular release of vaccine and cross-presentation of antigen can be fine-tuned via nanovACCine engineering.
Journal ArticleDOI
Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy.
Guizhi Zhu,Geoffrey M. Lynn,Orit Jacobson,Kai Chen,Yi Liu,Yi Liu,Huimin Zhang,Ying Ma,Fuwu Zhang,Rui Tian,Qianqian Ni,Siyuan Cheng,Zhantong Wang,Zhantong Wang,Nan Lu,Bryant C. Yung,Zhe Wang,Lixin Lang,Xiao Fu,Albert J. Jin,Ido D. Weiss,Harshad D. Vishwasrao,Gang Niu,Hari Shroff,Dennis M. Klinman,Robert A. Seder,Xiaoyuan Chen +26 more
TL;DR: The authors repurpose albumin-binding Evans blue to develop nanovaccines that co-deliver adjuvants and tumor neoantigens to antigen-presenting cells in lymph nodes, resulting in potent and durable antitumour immunity in combination immunotherapy.
Journal ArticleDOI
Solvent-Assisted Self-Assembly of a Metal-Organic Framework Based Biocatalyst for Cascade Reaction Driven Photodynamic Therapy.
Liangcan He,Liangcan He,Qianqian Ni,Jing Mu,Wenpei Fan,Lu Liu,Zhantong Wang,Ling Li,Wei Tang,Yijing Liu,Yaya Cheng,Longguang Tang,Zhen Yang,Yuan Liu,Jianhua Zou,Weijing Yang,Orit Jacobson,Fan Zhang,Pintong Huang,Xiaoyuan Chen +19 more
TL;DR: Inspired by biological transformation processes, effective biocatalytic cascades-driven photodynamic therapy in tumor-bearing mice is demonstrated by the integration of artificial enzyme with upconversion nanoparticles, providing Au-mediated cancer therapy via glucose oxidase-like catalytic activity.